Neurocrine Biosciences Highlights R&D Transformation
16 Dec 2025 //
PR NEWSWIRE
Neurocrine Reports Positive Ph 2 Osavampator Data In MDD
22 Sep 2025 //
PR NEWSWIRE
Neurocrine Biosciences to Unveil Osavampator Phase 2 Data
17 Sep 2025 //
PR NEWSWIRE
16 Dec 2025 //
PR NEWSWIRE
22 Sep 2025 //
PR NEWSWIRE
17 Sep 2025 //
PR NEWSWIRE
Market Place
Sourcing Support